
Jan 9 (Reuters) - The U.S. Environmental Protection Agency will reassess the safety of herbicide paraquat, its administrator Lee Zeldin said on Friday on X, adding that the body is requiring manufacturers to thoroughly prove that current uses are safe in real-world conditions.
Syngenta, which markets paraquat under the brand name Gramoxone, is among the herbicide's major sellers.
The Swiss-based agricultural chemical company is facing several lawsuits in the U.S., where plaintiffs allege exposure to paraquat caused them to develop Parkinson's, a degenerative brain disease that leads to loss of muscle coordination.
It has previously said there was "no credible evidence" that paraquat causes Parkinson's.
In agricultural settings, paraquat is mostly applied to soybean, corn and cotton crop fields to control invasive weeds and grasses, according to the Environmental Protection Agency.
(Reporting by Costas Pitas and Pooja Menon; Editing by Alan Barona)
LATEST POSTS
- 1
Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025 - 2
SpaceX launches Italian Earth-observing satellite to orbit on the 1st mission of 2026 (video) - 3
Medicine doesn’t just have ‘conscientious objectors’ − there are ‘conscientious providers,’ too - 4
Potential Houthi threat to Red Sea shipping could further damage global economy - 5
Decrease in Home Buy Credits and Home loan Renegotiating Rates: An Outline of Latest things
Figure out how to Amplify Your Open Record Reward
Lecturer who called Israel a terrorist state to remain Plaid Cymru candidate
Brazil approves law strengthening protective measures for female victims of gender-based violence
Cyber Monday 2025 streaming deal: Get $42 off six months of Apple TV
Moon rush: These private spacecraft will attempt lunar landings in 2026
Russia accidentally destroys its only way of sending astronauts to space
Instructions to Upgrade the Mechanical Highlights of Your Shrewd Bed for a Superior Night's Rest
Brazil's ex-president Bolsonaro operated on for hernia
Toyota Reports 2.3% Sales Drop as China Weakness Deepens












